A new study indicates that monitoring and modifying the pace of biological aging through biomarker testing could significantly reduce long-term healthcare costs and increase individual health value. Researchers utilized the DunedinPACE epigenetic clock to model how interventions starting at age 50 affect frailty, life expectancy, and economic outcomes, finding that slowing biological aging leads to substantial financial savings and improved qual…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.